US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67

+0.41001.04%

Post-market: 35.74-3.9300-9.91%19:30 EDT

Volume:75.38K

Turnover:2.97M

Market Cap:259.84M

PE:- -

High:39.69

Open:39.05

Low:39.05

Close:39.26

52wk High:41.49

52wk Low:22.18

Shares:6.55M

Float Shares:6.55M

Volume Ratio:0.54

T/O Rate:1.15%

Dividend:0.28

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Moderna rises 13.0%

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

Moderately bullish activity in Moderna with shares up 11.44%

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

Moderna Raised to Peer Perform from Underperform by Wolfe Research

What Happens if Moderna's Cancer Vaccine Works

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

Moderna on Track for Best Month on Record

Early notable gainers among liquid option names on August 25th

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100

Sagimet Biosciences advances AURORA clinical trial

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

Binance launches 5 stock perpetuals with 20x leverage

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IDNA/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":39.67,"timestamp":1788292800000,"preClose":39.26,"halted":0,"volume":75380,"hourTrading":{"tag":"盘后","latestPrice":35.74,"preClose":39.67,"latestTime":"19:30 EDT","volume":829,"amount":32033.95,"timestamp":1788305400694,"change":-3.93,"changeRate":-0.099067,"amplitude":0.099067},"delay":0,"changeRate":0.010443199184921134,"floatShares":6550000,"shares":6550000,"eps":0,"marketStatus":"Closed","change":0.41,"latestTime":"09-01 16:00:00 EDT","open":39.05,"high":39.6899,"low":39.05,"amount":2972722.6162,"amplitude":0.016299,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":39.26,"sharesOutstanding":5100000,"nav":39.190942,"aum":256700670.1,"dividendRate":0.007131,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.96,"preClose":39.26,"latestTime":"09:08 EDT","volume":3,"amount":119.110005,"timestamp":1788268100857,"change":0.7,"changeRate":0.01783,"amplitude":0.018085},"postHourTrading":{"tag":"盘后","latestPrice":35.74,"preClose":39.67,"latestTime":"19:30 EDT","volume":829,"amount":32033.95,"timestamp":1788305400694,"change":-3.93,"changeRate":-0.099067,"amplitude":0.099067},"volumeRatio":0.541742,"impliedVol":0.0718,"impliedVolPercentile":0.0556},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.541742,"shares":6550000,"dividePrice":0.2829,"high":39.6899,"amplitude":0.016299,"preClose":39.26,"low":39.05,"week52Low":22.18,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":39.67,"eps":0,"divideRate":0.007131,"volume":75380,"delay":0,"ttmEps":0,"open":39.05,"prevYearClose":26.19,"prevWeekClose":39.29,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":41.48,"twentyDayClose":32.9055,"sixtyDayClose":29.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662386751","title":"Moderna Shares Rise After Wolfe Research Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2662386751","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662386751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 02:20","pubTimestamp":1787682053,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) shares were up 13% in Tuesday trading after Wolfe Research upgraded the company's stock to peer perform from underperform.Trading volume stood at 37.2 million shares, compared with a daily average of 13.2 million.Price: 157.12, Change: +18.23, Percent Change: +13.12","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4588","BK4534","BK4551","BK4139","BK4585","BK4568","IDNA","LGHT","MRNY","BK4501","GNOM","BK4532","WDNA","BK4533","MRNX","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037756","title":"Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037756","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037756?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:59","pubTimestamp":1787677140,"startTime":"0","endTime":"0","summary":"1259 ET - Moderna's finding that the mRNA-based vaccine it made with Merck successfully prevented cancer from spreading or returning in melanoma patients is \"a big de-risking event for its personalized therapy approach,\" Wolfe Research analysts write in a note, upgrading the stock to peer perform from underperform. The market's ebullient response may suggest that some traders misunderstood the vaccine as a preventative treatment, they write, and Moderna may still not reach profitability until 2030. Still, the recent data, as well as Moderna's cost-cutting efforts and its patent litigation settlement with Arbutus Biopharma and Genevant Sciences GmbH, lead to a balanced risk/reward at the stock's current levels, the analysts write. Moderna's stock gains 14% to $158.10 and has nearly tripled in value over the past month.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNOM","BK4533","IDNA","MRNX","WDNA","BK4585","BK4139","BK4501","BK4532","LGHT","BK4534","BK4551","BK4568","BK4548","MRNY","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662475696","title":"Moderna rises 13.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662475696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662475696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:06","pubTimestamp":1787673960,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) is up 13.0%, or $18.02 to $156.91. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-rises-13-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-rises-13-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BK4532","BK4585","MRNX","GNOM","LGHT","WDNA","BK4139","BK4501","IDNA","BK4534","BK4533","MRNA","BK4568","BK4588","BK4551","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756858","title":"Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756858","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756858?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:00","pubTimestamp":1787673623,"startTime":"0","endTime":"0","summary":"Biotech firm Moderna ($MRNA) saw its stock rise 12.5% today, building on a multi-day rally after releasing positive Phase 3 trial data for its pers...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-rises-12-5-today-following-phase-3-mrna-cancer-vaccine-win-with-merck?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-rises-12-5-today-following-phase-3-mrna-cancer-vaccine-win-with-merck?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0965509283.SGD","SG9999001176.SGD","LU0098860793.USD","LU1201861249.SGD","LU1989771016.USD","MRNX","LU0980610538.SGD","LU1934455194.USD","LU2125909593.SGD","RXL","LU1941712348.USD","LU1035773651.USD","PAWZ","BK4548","SG9999001440.SGD","LU0203347892.USD","LU1989772923.USD","HRTS","PPH","SG9999015358.SGD","LU0689626769.HKD","LU2361044865.SGD","LU2324357040.USD","LU1430594728.SGD","LU2433249047.HKD","LU1934455277.USD","LU1093756168.USD","LU0942090050.USD","IE00BBT3K403.USD","LU1585245621.USD","LU1069347547.HKD","JDOC","LU0868494617.USD","GDOC","LU2023250504.SGD","LU0861579265.USD","LU0859254822.USD","IE00BLSP4452.SGD","LU1066051811.HKD","LU2089984988.USD","LU0130517989.USD","LU1983299246.USD","FHLC","LU0006306889.USD","LU1116320737.USD","LU1066051498.USD","LU1037948897.HKD","SG9999014559.SGD","LU1934455863.HKD","LGHT","SG9999014542.SGD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU0265550359.USD","BK4559","IE00BN8TJ469.HKD","LU0122379950.USD","LU1989772840.SGD","IE0009355771.USD","IE00BSNM7G36.USD","BK4551","LU0203345920.USD","LU2361045086.USD","LU1093756325.SGD","LU0965509101.SGD","LU1917777945.USD","LU2112291526.USD","MRNY","LU0868494708.USD","GNOM","LU1923622614.USD","BK4516","MRNA","IE00BJT1NW94.SGD","LU2491050154.USD","BMED","LU2491050071.SGD","BK4568","LU2361044949.HKD","LU0289739699.SGD","TRUH","LU0058720904.USD","LU0320765646.SGD","IE0002141913.USD","SG9999001176.USD","XLV","IE00BFTCPJ56.SGD","BK4139","LU1162221912.USD","LU2491049909.HKD","LU0238689110.USD","LU0070302665.USD","LU1037948541.HKD","LU0265550946.USD","FTXH","LU1116320901.HKD","VHT","LU1571399168.USD","LU1974910355.USD","IE00BLSP4239.USD","LU1699723380.USD","IE00B1BXHZ80.USD","LU0234572021.USD","LU2360032135.SGD","SGXZ57979304.SGD","LU0823416689.USD","LU0320765489.SGD","LU1066053197.SGD","SG9999014575.USD","SG9999013999.USD","IE00B4R5TH58.HKD","SG9999014567.USD","LU0985320562.USD","LU0124676726.USD","IYH","LU1061106388.HKD","BK4585","LU1066051225.USD","WDNA","LU1291159041.SGD","IHE","LU1023059063.AUD","BK4588","IE00B2B36J28.USD","IE000M9KFDE8.USD","LU2125154935.USD","LU0477156953.USD","LU1941712264.USD","IXJ","LU2125909247.SGD","BK4550","LU0106261372.USD","LU0211331839.USD","LU0432979614.USD","LU0266013472.USD","LU2023250843.SGD","LU0648001328.SGD","SG9999002232.USD","BK4533","LU1929549753.HKD","MRK","LU2461242641.AUD","LU2106854487.HKD","LU0208291251.USD","BK4007","LU0130102774.USD","SG9999015341.SGD","LU2468319806.SGD","BK4532","LU1057294990.SGD","BK4501","IDNA","LU2125154778.USD","LU2357627491.SGD","BK4534","LU0965508806.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530807","title":"Moderately bullish activity in Moderna with shares up 11.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530807?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:50","pubTimestamp":1787669413,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares up $15.88, or 11.44%, near $154.78. Options volume more than double the daily average wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-11-44-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-11-44-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNA","BK4532","IDNA","MRNX","BK4568","BK4533","BK4588","BK4548","BK4551","BK4501","BK4585","MRNY","GNOM","WDNA","BK4534","BK4139","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662530687","title":"BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530687","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530687?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:45","pubTimestamp":1787669120,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the U.S. FDA has approved the supplemental Biologics License Application for TEVIMBRA in combination with ZIIH...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-announces-fda-approval-for-tevimbra-based-reginmen-for-her2-gea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","TECB","FRTY","BK4585","IYH","BMED","MRNX","SYNB","RSPH","TBXU","XLVX","PSCH","BBP","NVIB","IDNA","ONC","IEIH","BK4588","MRNY","GNMX","BK4526","BK4139","LFSC","GDOC","PINK","LABU","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662535777","title":"Moderna Raised to Peer Perform from Underperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662535777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662535777?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:39","pubTimestamp":1787668740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4568","BK4501","BK4548","BK4534","BK4551","MRNA","BK4139","BK4588","BK4585","GNOM","MRNX","WDNA","IDNA","MRNY","LGHT","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662544753","title":"What Happens if Moderna's Cancer Vaccine Works","url":"https://stock-news.laohu8.com/highlight/detail?id=2662544753","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662544753?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:38","pubTimestamp":1787668680,"startTime":"0","endTime":"0","summary":"The latest trial results from Moderna have brought a personalized cancer vaccine within striking distance of reality. The risks are real, but the potential is undeniable: What will it mean if this therapy actually crosses the finish line?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNX","BK4139","BK4585","MRNA","MRNY","IDNA","WDNA","BK4501","BK4588","LGHT","BK4532","BK4551","GNOM","BK4568","BK4548","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175807","title":"U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175807","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175807?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:23","pubTimestamp":1787667780,"startTime":"0","endTime":"0","summary":"Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, providing a new treatment option in front-li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350636/0/en/u-s-fda-approves-ziihera-zanidatamab-hrii-with-and-without-tislelizumab-plus-chemotherapy-in-first-line-her2-advanced-gastroesophageal-adenocarcinoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPI","BTCI","BTCC","NVIB","FBTC","CBXY","BTCZ","DEFI","BITX","CBXO","ARKB","MNRS","CBTJ","CBTO","BCCC","BTF","YBTC","BMED","BITB","GDOC","CBTA","BTCL","CBXJ","CBOA","BITI","AEIS","CBTY","LABU","BITY","CBOJ","XBTY","GBTC","CRC","BTCW","CBOY","BFJL","HODL","MAXI","EZBC","DFII","IBIT","BTC","BRRR","BTCO","BITU","IDNA","BFAP","BTRN","BITO","SBIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758029","title":"Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758029","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758029?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:15","pubTimestamp":1787667315,"startTime":"0","endTime":"0","summary":"• Moderna shares rallied following Wall Street upgrades and positive oncology trial results.\n• Phase 3 INTerpath-001 trial results showed significant reduction in melanoma recurrence.\n• Heavy short-covering activity and bullish technical indicators accelerated the stock's upward move.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262130677-market-movers-mrna-20260825","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","AGNG","IE0004445239.USD","IE00BFSS8Q28.SGD","LU1221951046.USD","MEDI","MRNY","MRNX","GNOM","IHE","XLV","LLYX","LLYZ","IDNA","FHLC","THNR","LLII","WDNA","LU0823416689.USD","RXL","ELIS","FTXH","BMED","LU2417539215.USD","TMED","CANC","LU1712237335.SGD","LLY","LGHT","OZEM","ELIL","HRTS","IE00BN29S564.USD","IXJ","GDOC","TRUH","MEDX","LU1221951129.SGD","LU2361045086.USD","PJP","IYH","IE00B775H168.HKD","PPH","ILDR","JNJ","VHT","LU1974910355.USD","MRNA","JDOC","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758856","title":"Moderna on Track for Best Month on Record","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758856","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758856?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:00","pubTimestamp":1787666400,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  is currently at $151.90, up $13.01 or 9.37%--On pace for largest percent increase since Aug. 19, 2026, when it rose 176.97%--Currently up three of the past five days--Up 177.09% month-to-date; on pace for best month on record --Up 415.09% year-to-date--Down 68.65% from its all-time closing high of $484.47 on Aug. 9, 2021--Up 514.23% from 52 weeks ago , when it closed at $24.73--Down 12.89% from its 52-week closing high of $174.38 on Aug. 19, 2026--Up 579.34% from its 52-week closing low of $22.36 on Nov. 20, 2025--Traded as high as $154.27--Up 11.07% at today's intraday high--Best performer in the S&P 500 today--Fifth most active stock in the S&P 500 todayAll data as of 9:57:26 AM ETSource: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","MRNY","WDNA","BK4551","BK4139","BK4568","MRNX","IDNA","BK4548","BK4501","MRNA","BK4585","BK4533","GNOM","BK4534","LGHT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758844","title":"Early notable gainers among liquid option names on August 25th","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662758844?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:55","pubTimestamp":1787666119,"startTime":"0","endTime":"0","summary":"Notable gainers among liquid option names this morning include Moderna (MRNA) $153.72 +14.83, Super Micro (SMCI) $37.78 +2.61, Marvell (MRVL) $245....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-august-25th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-august-25th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GTEK","BK4501","SMCZ","SMCX","LU2473716301.USD","LU1548497426.USD","LU1989764748.USD","IE0004091025.USD","LU2357305700.SGD","LU0823421416.USD","LU1642822529.SGD","LU1861215975.USD","LU1119994496.HKD","BK4581","LGHT","FAI","MRNA","LU2360107168.USD","BK4604","GNOM","LU0056508442.USD","LU1992135472.HKD","LU1084165304.USD","SMCI","BK4568","IE00BMPRXR70.SGD","LU0081259029.USD","LU1823568750.SGD","LU1989764664.SGD","FDTX","ARTY","BK4141","MRVL","LU1815336760.USD","LU1720051108.HKD","WUGI","LU2458330243.SGD","DTCR","LU0823434583.USD","LU2089985449.USD","BK4548","IDNA","LU1261432733.SGD","BK4533","LU2322448957.HKD","LU0476273544.USD","IE0004086264.USD","LU0053671581.USD","LU2098885051.SGD","LU1720051017.SGD","LU2322448791.USD","LU1235294995.USD","BK4543","SOXY","IE00BBT3K403.USD","MRVU","BK4551","LU0444973449.USD","LU1861220033.SGD","SG9999000418.SGD","LU0187121727.USD","LU2290526834.HKD","LU1046421795.USD","BK4515","SMHX","FTXL","WDNA","IE00BLSP4239.USD","MRNY","LU1303367103.USD","LU1169590202.USD","BK4532","LU0642271901.SGD","BK4534","IE00BMPRXQ63.HKD","LU2458330169.SGD","BK4588","LU0444971666.USD","MVLL","MRVX","LU1852331112.SGD","LU0957808578.USD","LU2931357623.SGD","BK4605","SMYY","AIS","LU0823434740.USD","AIFD","IE00BLSP4452.SGD","LU0274383776.USD","BK4170","LU0061475181.USD","MRNX","LU0823421333.USD","LU2272731865.HKD","LU1316542783.SGD","BK4585","LU1169589451.USD","LU0786609619.USD","SMCY","LU2272731600.USD","FXL","XNTK","SMCL","BK4139","LU2244417387.USD","LU2543165471.USD","QQQA","IE00BMPRXN33.USD","LU1992135399.USD","LU0127658192.USD","IE00BN8TJ469.HKD","LU0154236417.USD","LU2272731782.SGD","SMCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662730978","title":"Moderna Shares up 8.4% as Barclays Hikes Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662730978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662730978?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:44","pubTimestamp":1787665459,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4532","BK4548","BK4139","BK4588","BK4501","BK4568","MRNA","MRNX","MRNY","WDNA","BK4585","BK4551","BK4533","IDNA","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737518","title":"After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737518","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662737518?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:00","pubTimestamp":1787662814,"startTime":"0","endTime":"0","summary":"WSW, NY, August 25th, 2026, FinanceWire Moderna’s cancer news sent its stock up 177% in a single day (NASDAQ:MRNA), from $62.96 to $174.38. Roughly...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/after-modernas-44b-oncology-win-silexions-pancreatic-cancer-treatment-is-worth-exploring-nasdaq-slxn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNA","BK4551","QLD","FTEC","GNOM","BK4585","QQQE","PSQ","TQQY","MRNY","LGHT","BK4532","NQmain","BK4501","BK4548","QQQA","TQQQ","BK4139","BK4588","ONEQ","SLXN","BK4533",".IXIC","MNQmain","JEPQ","NDX","MRNX","QQQY","QDTE","BK4568","NVIW.SI","QQQM","QYLG","TECS","BK4534","QID","QQQJ","QQQ","SQQQ","IDNA","IYW","GPIQ","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732058","title":"Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732058","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732058?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:55","pubTimestamp":1787662500,"startTime":"0","endTime":"0","summary":"President & CEO, Sabrina Martucci Johnson, discusses the Company's shift to commercial stage, upcoming revenue opportunities, Ovaprene's positive interim Phase 3 results and what could drive value ove","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","IDNA","03160","LABU","TM","BK4007","BK4588","BK4584","BK4099","NVIB","DARE","BK4585","HYLG","BK4604","MEDX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732665","title":"RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732665","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732665?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:30","pubTimestamp":1787661000,"startTime":"0","endTime":"0","summary":"PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350436/0/en/renovorx-highlights-peer-reviewed-publication-of-pharmacokinetic-and-pharmacodynamic-pk-pd-data-supporting-tamp-platform-s-targeted-drug-delivery-in-locally-advanced-pancreatic-can.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","HYLG","LU0345780281.USD","IDNA","LU2089985449.USD","LU1169590202.USD","BK4588","PK","RNXT","IE00B19Z4B17.USD","BK4139","LU2931357623.SGD","GDOC","IE00B66KJ199.SGD","LU0274383776.USD","IAG","BK4585","IE0009354923.USD","BK4539","LABU","BK4181","BK4157","MEDX","BK4017","LU0345780521.USD","AEIS","BK4183","LU1169589451.USD","IE00B7SZL793.SGD","BK4023","LU0757428866.USD","ODD","IE0031619046.USD","NVIB","KBWY","LU1815336091.USD","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662873429","title":"GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100","url":"https://stock-news.laohu8.com/highlight/detail?id=2662873429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662873429?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:15","pubTimestamp":1787660116,"startTime":"0","endTime":"0","summary":"Lokahi Therapeutics, a subsidiary of Glucotrack (GCTK), announced that it has started its initial Good Manufacturing Practice, GMP, manufacturing c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/glucotrack-subsidiary-initiates-clinical-trial-manufacturing-for-lt-100-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/glucotrack-subsidiary-initiates-clinical-trial-manufacturing-for-lt-100-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","NVIB","EES","MEDX","IDNA","GCTK","GDOC","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662773162","title":"Sagimet Biosciences advances AURORA clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662773162","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662773162?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:40","pubTimestamp":1787658027,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) announced that its AURORA Phase 3 clinical trial of FASN inhibitor denifanstat in moderate to severe acne is on track to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-advances-aurora-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-advances-aurora-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","IDNA","NVIB","BK4139","HYLG","GDOC","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662336117","title":"Moderna upgraded to Peer Perform from Underperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662336117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662336117?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:46","pubTimestamp":1787651170,"startTime":"0","endTime":"0","summary":"Wolfe Research upgraded Moderna (MRNA) to Peer Perform from Underperform without a price target The firm says the positive melanoma trial de-risks ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-upgraded-to-peer-perform-from-underperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","MRNY","WDNA","BK4551","BK4139","BK4568","MRNX","IDNA","BK4548","BK4501","MRNA","BK4585","BK4533","GNOM","BK4534","LGHT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781125","title":"Binance launches 5 stock perpetuals with 20x leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781125","media":"cryptonews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781125?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:21","pubTimestamp":1787642512,"startTime":"0","endTime":"0","summary":"Binance Futures launched five USDT-margined TradFi perpetual contracts on Aug. 25, giving eligible traders leveraged exposure to Trump Media, Moderna and three semiconductor-focused exchange-traded funds.Binance launched five USDT margined perpetual contracts tied to U.S. stocks and leveraged exchange-traded funds.Contracts offer up to 20x leverage, round-the-clock trading and eight-hour funding settlements through Binance Futures.SKUU and SKDD track daily moves in SK Hynix, while RAM references leveraged DRAM exposure.DJT and MRNA perpetuals reference Trump Media and Moderna shares without granting stock ownership rights.Each contract uses USDT for settlement and requires a minimum notional trade worth five dollars.The contracts began trading at five-minute intervals between 09:00 and 09:20 UTC. Binance listed SKUUUSDT, SKDDUSDT, RAMUSDT, DJTUSDT and MRNAUSDT with maximum leverage of 20x.The long fund seeks twice the daily percentage change in SK Hynix’s U.S.-listed depositary receipt","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/binance-launches-5-stock-perpetuals-with-20x-leverage/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["LGHT","IDNA","RAM","BK4532","BK4501","07709","MRNY","RAMZ","SK","DRAL","SKDD","GNOM","DJTU","SKHU","BK4547","SKHA","DRAM","WDNA","BK4516","SKHZ","MRNA","SKHY","MRNX","SKUU","BK4548","BK4588","BK4585","BK4534","BK4139","BK4077","TRUMP.USD.CC","BK4568","BK4551","DJT","BK4533","HYNX","SKHX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":7,"totalSize":325,"code":"91000000","status":"200"}]}}